Literature DB >> 15259866

The treatment of status epilepticus.

James J Riviello1, Gregory L Holmes.   

Abstract

Status epilepticus (SE) is a life-threatening emergency that requires prompt treatment, including basic neuroresuscitation principles (the ABCs), antiepileptic drugs to stop the seizure, and identification of etiology. Symptomatic SE is more common in younger children. Treating the precipitating cause may prevent ongoing neurologic injury and facilitates seizure control. A systematic treatment regimen, planned in advance, is needed, including one for refractory status epilepticus (RSE). Here we emphasize definitions, clinical and electroencephalography stages, early treatment, special circumstances that may require immediate seizure control, and treatment of RSE. Because much clinical research in SE has been done in adults, we indicate the patient population studied.

Entities:  

Mesh:

Year:  2004        PMID: 15259866     DOI: 10.1016/j.spen.2004.03.011

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  5 in total

1.  Subunit-specific trafficking of GABA(A) receptors during status epilepticus.

Authors:  Howard P Goodkin; Suchitra Joshi; Zakaria Mtchedlishvili; Jasmit Brar; Jaideep Kapur
Journal:  J Neurosci       Date:  2008-03-05       Impact factor: 6.167

2.  Status Epilepticus in Children.

Authors:  K Behera; S Rana; M Kanitkar; M Adhikari
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Status epilepticus: Role for etiology in determining response to benzodiazepines.

Authors:  Suchitra Joshi; Karthik Rajasekaran; Kyle M Hawk; Stephen J Chester; Howard P Goodkin
Journal:  Ann Neurol       Date:  2018-04-10       Impact factor: 10.422

Review 4.  Anesthesia for epilepsy surgery in children.

Authors:  Sulpicio G Soriano; Patrizia Bozza
Journal:  Childs Nerv Syst       Date:  2006-06-20       Impact factor: 1.475

5.  Guidelines for the evaluation and management of status epilepticus.

Authors:  Gretchen M Brophy; Rodney Bell; Jan Claassen; Brian Alldredge; Thomas P Bleck; Tracy Glauser; Suzette M Laroche; James J Riviello; Lori Shutter; Michael R Sperling; David M Treiman; Paul M Vespa
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.